BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28039579)

  • 1. Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer.
    Jia F; Teer JK; Knepper TC; Lee JK; Zhou HH; He YJ; McLeod HL
    Mol Diagn Ther; 2017 Apr; 21(2):179-185. PubMed ID: 28039579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: meta-analysis, co-occurrence and ethnic variation.
    Chong ML; Loh M; Thakkar B; Pang B; Iacopetta B; Soong R
    Int J Cancer; 2014 Mar; 134(5):1232-8. PubMed ID: 23960014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.
    Kim Y; Hammerman PS; Kim J; Yoon JA; Lee Y; Sun JM; Wilkerson MD; Pedamallu CS; Cibulskis K; Yoo YK; Lawrence MS; Stojanov P; Carter SL; McKenna A; Stewart C; Sivachenko AY; Oh IJ; Kim HK; Choi YS; Kim K; Shim YM; Kim KS; Song SY; Na KJ; Choi YL; Hayes DN; Kim J; Cho S; Kim YC; Ahn JS; Ahn MJ; Getz G; Meyerson M; Park K
    J Clin Oncol; 2014 Jan; 32(2):121-8. PubMed ID: 24323028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
    van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
    Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
    Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
    Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    Li G; Guo X; Chen M; Tang L; Jiang H; Day JX; Xie Y; Peng L; Xu X; Li J; Wang S; Xiao Z; Dai L; Wang J
    PLoS One; 2018; 13(9):e0203495. PubMed ID: 30212483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal Cell Carcinoma Gene Mutations Differ Between Asian, Hispanic, and Caucasian Patients: A Pilot Study.
    Lobl M; Hass B; Clarey D; Higgins S; Sutton A; Wysong A
    J Drugs Dermatol; 2021 May; 20(5):504-510. PubMed ID: 33938707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
    Wang Q; Xie Q; Liu Y; Guo H; Ren Y; Li J; Zhao Q
    Mol Med Rep; 2020 Aug; 22(2):828-840. PubMed ID: 32468041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
    Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
    APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of co-occurring mutations of specific tumor suppressor genes in lung adenocarcinoma between Asian and Caucasian populations.
    Zhang Y; Ma Y; Li Y; Shen X; Yu Y; Pan Y; Zhang Y; Zheng D; Zhao Y; Ye T; Li B; Hu H; Sun Y; Zhang Y; Xiang J; Chen H
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):747-757. PubMed ID: 30673871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.
    Becerra MF; Reznik E; Redzematovic A; Tennenbaum DM; Kashan M; Ghanaat M; Casuscelli J; Manley B; Jonsson P; DiNatale RG; Blum KA; Durack JC; Solomon SB; Arcila ME; Bourque C; Socci N; Carlo MI; Lee CH; Voss MH; Feldman DR; Motzer RJ; Coleman JA; Russo P; Cheng EH; Hakimi AA; Hsieh JJ
    Eur Urol Focus; 2018 Dec; 4(6):986-994. PubMed ID: 29066084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort.
    Röcken C; Behrens HM; Böger C; Krüger S
    J Clin Pathol; 2016 Jan; 69(1):70-5. PubMed ID: 26251521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer.
    Zhang QY; Cheng WX; Li WM; Au W; Lu YY
    Mutat Res; 2014 Nov; 769():108-12. PubMed ID: 25771729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathway-centric survey of somatic mutations in Chinese patients with colorectal carcinomas.
    Ling C; Wang L; Wang Z; Xu L; Sun L; Yang H; Li WD; Wang K
    PLoS One; 2015; 10(1):e0116753. PubMed ID: 25617745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations.
    Deng J; Chen H; Zhou D; Zhang J; Chen Y; Liu Q; Ai D; Zhu H; Chu L; Ren W; Zhang X; Xia Y; Sun M; Zhang H; Li J; Peng X; Li L; Han L; Lin H; Cai X; Xiang J; Chen S; Sun Y; Zhang Y; Zhang J; Chen H; Zhang S; Zhao Y; Liu Y; Liang H; Zhao K
    Nat Commun; 2017 Nov; 8(1):1533. PubMed ID: 29142225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
    Steuer CE; Behera M; Berry L; Kim S; Rossi M; Sica G; Owonikoko TK; Johnson BE; Kris MG; Bunn PA; Khuri FR; Garon EB; Ramalingam SS
    Cancer; 2016 Mar; 122(5):766-72. PubMed ID: 26695526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
    Toomey S; Eustace AJ; Fay J; Sheehan KM; Carr A; Milewska M; Madden SF; Teiserskiene A; Kay EW; O'Donovan N; Gallagher W; Grogan L; Breathnach O; Walshe J; Kelly C; Moulton B; Kennedy MJ; Gullo G; Hill AD; Power C; Duke D; Hambly N; Crown J; Hennessy BT
    Breast Cancer Res; 2017 Jul; 19(1):87. PubMed ID: 28750640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing.
    Jia M; Liao N; Chen B; Zhang G; Wang Y; Li X; Cao L; Mok H; Ren C; Li K; Li C; Wen L; Lin J; Wei G; Balch CM
    Breast Cancer; 2021 May; 28(3):644-652. PubMed ID: 33386585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.